246 related articles for article (PubMed ID: 10585311)
1. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
Braun MC; West CD; Strife CF
Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
[TBL] [Abstract][Full Text] [Related]
2. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[TBL] [Abstract][Full Text] [Related]
6. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
Strife CF; Jackson EC; McAdams AJ
Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological survey of persistent hypocomplementemic glomerulonephritis in children; correlation of DPGN and MPGN type I].
Hattori S; Hiramatsu M; Ushijima T; Karashima S; Furuse A; Matsuda I; Takebayashi S
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):773-81. PubMed ID: 1479716
[TBL] [Abstract][Full Text] [Related]
8. Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.
McEnery PT; McAdams AJ; West CD
Clin Nephrol; 1980 Mar; 13(3):117-24. PubMed ID: 7379361
[TBL] [Abstract][Full Text] [Related]
9. The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis.
McEnery PT; McAdams AJ; West CD
Medicine (Baltimore); 1985 Nov; 64(6):401-24. PubMed ID: 2414636
[TBL] [Abstract][Full Text] [Related]
10. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
11. Type 3 membranoproliferative glomerulonephritis: clinicopathologic correlations and long-term follow-up in nine patients.
Abreo K; Moorthy AV
Arch Pathol Lab Med; 1982 Aug; 106(8):413-7. PubMed ID: 6896632
[TBL] [Abstract][Full Text] [Related]
12. Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.
Bergstein JM; Andreoli SP
Pediatr Nephrol; 1995 Jun; 9(3):268-71. PubMed ID: 7632508
[TBL] [Abstract][Full Text] [Related]
13. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.
Braun MC; Stablein DM; Hamiwka LA; Bell L; Bartosh SM; Strife CF
J Am Soc Nephrol; 2005 Jul; 16(7):2225-33. PubMed ID: 15888559
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
[TBL] [Abstract][Full Text] [Related]
16. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
[TBL] [Abstract][Full Text] [Related]
17. A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
Kano K; Nishikura K; Kojima M; Yamada Y; Arisaka O; Tomita S; Shimotsuji T; Fujikawa Y; Inafuku S; Imakita M; Ueda Y
Clin Exp Nephrol; 2003 Jun; 7(2):157-62. PubMed ID: 14586735
[TBL] [Abstract][Full Text] [Related]
18. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
Iitaka K; Yamamoto A; Ogawa N; Sekine T; Tamai S; Motoyama O
Clin Exp Nephrol; 2003 Dec; 7(4):284-9. PubMed ID: 14712358
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S; Mahajan SK; Sen R; Sharma A
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[TBL] [Abstract][Full Text] [Related]
20. Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal.
Kazama I; Matsubara M; Ejima Y; Michimata M; Suzuki M; Miyama N; Sato A; Sato H; Ito S
Clin Exp Nephrol; 2005 Mar; 9(1):62-8. PubMed ID: 15830276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
